Last reviewed · How we verify
Enterobacter Pelvic Inflammatory Disease
Approved treatments
- Claforan · Sterimax
- Azactam · Bristol-Myers Squibb
Aztreonam inhibits bacterial cell wall synthesis, acting as a bactericidal agent.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Enterobacter Pelvic Inflammatory Disease patent landscape — cliff calendar, originator estates, attackable patents
- Enterobacter Pelvic Inflammatory Disease treatment landscape brief
- Enterobacter Pelvic Inflammatory Disease treatment updates RSS
Frequently asked questions about Enterobacter Pelvic Inflammatory Disease
What drugs treat Enterobacter Pelvic Inflammatory Disease?
Tracked treatments include Claforan, Azactam.
What is the treatment for Enterobacter Pelvic Inflammatory Disease?
Standard treatment for Enterobacter Pelvic Inflammatory Disease includes Claforan, Azactam. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Enterobacter Pelvic Inflammatory Disease patent cliff · Enterobacter Pelvic Inflammatory Disease CI report
- Treatment: Claforan · Sterimax
- Treatment: Azactam · Bristol-Myers Squibb
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing